More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Approval Received for Distribution of CannEpil into Ireland

Dec 2, 2019 at 11:05 PM EST · Issued by Argent Biopharma Ltd

Filed with ASX · Dec 2, 2019 at 11:05 PM EST

On 6ix: 6ix.com/news/approval-received-for-distribution-of-cannepil-into-ireland

Argent Biopharma Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Story so far

  • Epilepsy Clinical Study Comparing CannEpil to 100% CBDSep 3, 2019
  • Trial on the Effect of CannEpil on Driver CompetencyAug 23, 2019
  • Germany, Austria & Switzerland Distribution Agreement SignedJun 21, 2019

Earlier from Argent Biopharma

  • Growth in Prescriptions Issued Continues During NovemberNov 25, 2019
  • Binding Term Sheet to Immediately Expand into Latin AmericaNov 21, 2019
  • Pause in TradeNov 20, 2019
  • MGC Reaches 1,000 Prescription Milestone Ahead of ScheduleOct 30, 2019
  • 800 Prescription Milestone Passed for MGC Pharma ProductsOct 23, 2019

Later from Argent Biopharma

  • Prescriptions Grow Above 1,800 & First Ireland PrescriptionsDec 16, 2019
  • First Shipment of CogniCann en route to AustraliaDec 18, 2019
  • Launch of New Product Line in Aus & NZ - Mercury PharmaJan 6, 2020
  • MGC Pharma Crosses 2,000 Prescription MilestoneJan 8, 2020
  • Supply Agreement with THC Global for Canndeo ProductsJan 19, 2020
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer